Breaking News Instant updates and real-time market news.

09:00
08/29/18
08/29
09:00
08/29/18
09:00

The U.S. Q2 GDP growth boost to 4.2%

The U.S. Q2 GDP growth boost to 4.2% from 4.1% beat estimates thanks to a larger than expected $6.2 B net export hike, alongside small unexpected boosts in public construction and equipment spending, while inventories were lifted $1.0 B rather than trimmed. Analysts also saw an expected big boost for intellectual property investment, and expected small downward bumps for consumption and residential construction. Final sales growth was raised to a robust 5.3% from 5.1%. Analysts left our Q3 GDP growth estimate at 3.5%. The Q2 data show a hefty $57.3 (was $58.3) B inventory subtraction, leaving a big $26.9 (was $27.9) B liquidation rate that marks the largest pull-back since the last recession. Beyond inventories, Q2 GDP revealed solid growth in consumption after a weak Q1, and a robust path for business fixed investment. Government purchases rose in Q2 with help from the budget deal, and residential construction gave back some of its big Q4-Q1 post-hurricane gain. Analysts saw robust Q2 export growth that reflects both faster global GDP growth and a front-running by exporters ahead of Q3 tariffs, with a surge in soy bean exports and a drop in soy bean inventories, leaving Q2 trade and inventory gyrations that were largely offsetting for GDP, and that will presumably be reversed in Q3.

TODAY'S FREE FLY STORIES

NBIX

Neurocrine

$85.72

-0.14 (-0.16%)

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Hot Stocks
Breaking Hot Stocks news story on Neurocrine »

Neurocrine trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Recommendations
Tesla analyst commentary  »

Tesla poised to exceed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

LULU

Lululemon

$116.67

1.66 (1.44%)

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Upgrade
Lululemon rating change  »

Citi upgrades Lululemon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

UAA

Under Armour

$22.14

-0.25 (-1.12%)

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Conference/Events
Under Armour to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 14

    Dec

AIMT

Aimmune

$23.25

0.18 (0.78%)

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Conference/Events
Aimmune to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

UA

Under Armour

$20.87

-0.15 (-0.71%)

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Conference/Events
Under Armour to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 03

    Mar

EBAY

eBay

$29.05

0.07 (0.24%)

07:24
12/12/18
12/12
07:24
12/12/18
07:24
Downgrade
eBay rating change  »

Morgan Stanley admits to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

AAPL

Apple

$168.66

-0.95 (-0.56%)

07:20
12/12/18
12/12
07:20
12/12/18
07:20
Periodicals
Apple mulls shifting iPhone production if tariffs hit 25%, Bloomberg reports »

Apple suppliers will mull…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHPG

Shire

$169.68

-0.44 (-0.26%)

, TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

07:20
12/12/18
12/12
07:20
12/12/18
07:20
Downgrade
Shire, Takeda Pharmaceutical rating change  »

Shire downgraded to Hold…

SHPG

Shire

$169.68

-0.44 (-0.26%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 21

    Dec

  • 11

    Jan

07:20
12/12/18
12/12
07:20
12/12/18
07:20
General news
FX Update: The dollar has been trading mixed-to-firmer »

FX Update: The dollar has…

07:17
12/12/18
12/12
07:17
12/12/18
07:17
General news
Futures higher following release of Huawei CFO »

Stock futures are…

CORT

Corcept Therapeutics

$17.16

4.18 (32.20%)

07:17
12/12/18
12/12
07:17
12/12/18
07:17
Upgrade
Corcept Therapeutics rating change  »

Cantor upgrades Corcept…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DCO

Ducommun

$38.00

0.2 (0.53%)

07:13
12/12/18
12/12
07:13
12/12/18
07:13
Initiation
Ducommun initiated  »

Ducommun initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSDT

Helius Medical

$9.94

-0.33 (-3.21%)

07:12
12/12/18
12/12
07:12
12/12/18
07:12
Hot Stocks
Helius Medical announces PoNS application for CE Mark »

Helius Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCI

Intra-Cellular

$15.50

0.16 (1.04%)

07:12
12/12/18
12/12
07:12
12/12/18
07:12
Recommendations
Intra-Cellular analyst commentary  »

Intra-Cellular's NDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

MNGPY

Man Group

$0.00

(0.00%)

07:11
12/12/18
12/12
07:11
12/12/18
07:11
Downgrade
Man Group rating change  »

Man Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCY

Oncolytics

$2.03

0.01 (0.50%)

, BMY

Bristol-Myers

$52.44

-0.15 (-0.29%)

07:10
12/12/18
12/12
07:10
12/12/18
07:10
Hot Stocks
Oncolytics treats first patient in pelareorep, carfilzomib with Opdivo trial »

Oncolytics (ONCY)…

ONCY

Oncolytics

$2.03

0.01 (0.50%)

BMY

Bristol-Myers

$52.44

-0.15 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 29

    Dec

  • 24

    Jan

  • 20

    May

UNIT

Uniti Group

$19.59

0.52 (2.73%)

07:10
12/12/18
12/12
07:10
12/12/18
07:10
Downgrade
Uniti Group rating change  »

Uniti Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$207.29

-0.545 (-0.26%)

07:09
12/12/18
12/12
07:09
12/12/18
07:09
Hot Stocks
Lennox sees $347M in insurance proceeds for 2018, 2019 »

Overall for 2018 and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SRNE

Sorrento Therapeutics

$2.66

-0.27 (-9.22%)

07:08
12/12/18
12/12
07:08
12/12/18
07:08
Recommendations
Sorrento Therapeutics analyst commentary  »

Sorrento Therapeutics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDR

McDermott

$7.28

-0.37 (-4.84%)

, GE

General Electric

$6.77

-0.15 (-2.17%)

07:08
12/12/18
12/12
07:08
12/12/18
07:08
Hot Stocks
McDermott, Baker Hughes, selected for Equus Gas Project in Australia »

McDermott (MDR), with…

MDR

McDermott

$7.28

-0.37 (-4.84%)

GE

General Electric

$6.77

-0.15 (-2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$135.79

2.32 (1.74%)

07:08
12/12/18
12/12
07:08
12/12/18
07:08
Hot Stocks
Molina Healthcare awarded CHIP contract in Mississippi »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVEO

Aveo Pharmaceuticals

$2.03

0.01 (0.50%)

, AZN

AstraZeneca

$38.63

0.22 (0.57%)

07:08
12/12/18
12/12
07:08
12/12/18
07:08
Hot Stocks
Aveo Oncology announces immuno-oncology clinical collaboration with AstraZeneca »

AVEO Oncology (AVEO)…

AVEO

Aveo Pharmaceuticals

$2.03

0.01 (0.50%)

AZN

AstraZeneca

$38.63

0.22 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRMN

Garmin

$65.37

0.41 (0.63%)

07:08
12/12/18
12/12
07:08
12/12/18
07:08
Hot Stocks
Garmin Health, ActiGraph collaborate on wearable solutions for clinical trials »

Garmin International, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

BIOS

BioScrip

$3.84

0.1 (2.67%)

07:08
12/12/18
12/12
07:08
12/12/18
07:08
Initiation
BioScrip initiated  »

BioScrip initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.